PEAK6 Investments’s Cantel Medical Corporation CMD Stock Holding History

PEAK6 Investments’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,507	Closed	-$120K	–	6134
2021 Q1	$120K	Sell	1,507 -1,970	-57%	-$154K	﹤0.01%	4201
2020 Q4	$274K	Buy	+3,477	New	+$204K	﹤0.01%	3557
2020 Q3	–	Sell	-1,183	Closed	-$58.3K	–	5127
2020 Q2	$52K	Sell	1,183 -4,093	-78%	-$153K	﹤0.01%	4002
2020 Q1	$189K	Buy	+5,276	New	+$300K	﹤0.01%	2903
2019 Q4	–	Sell	-6,224	Closed	-$466K	–	4315
2019 Q3	$466K	Sell	6,224 -17,811	-74%	-$1.51M	﹤0.01%	2325
2019 Q2	$1.94M	Buy	+24,035	New	+$1.69M	0.01%	1315
2018 Q4	–	Sell	-5,882	Closed	-$486K	–	4960
2018 Q3	$541K	Buy	+5,882	New	+$560K	﹤0.01%	2501

PEAK6 Investments's CMD Position: Q2 2021 in Review

PEAK6 Investments sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,507 shares — an estimated $120K sold.

PEAK6 Investments first reported a position in CMD in Q3 2018 and held it in 7 quarters. The position peaked at $1.94M in Q2 2019. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.

PEAK6 Investments reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
PEAK6 Investments sold 1,507 Cantel Medical Corporation shares in Q2 2021, an estimated $120K.
PEAK6 Investments first reported a position in Cantel Medical Corporation in Q3 2018 and held it in 7 quarters.
PEAK6 Investments's Cantel Medical Corporation position peaked at $1.94M in Q2 2019.
0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.

Based on PEAK6 Investments's 13F filing for Q2 2021, filed 13 Aug 2021.